Heritage Global (HGBL) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
23 Nov, 2025Executive summary
Q2 2025 operating income was $2.2M, down from $3.5M in Q2 2024, with net income at $1.6M ($0.05 per diluted share), reflecting lower year-over-year earnings despite revenue growth to $14.3M.
Management expressed high confidence in stability and growth, supported by a strong, diversified pipeline, ongoing client additions, and robust operational execution.
The company is in acquisition mode, actively evaluating multiple deals with a strong cash position and intent to announce transactions within 6-12 months.
Repurchased 744,424 shares for $1.6M in Q2 2025 and authorized a new $7.5M buyback program through June 2028.
Acquisition of a new corporate headquarters and investment in a pharmaceutical plant impacted working capital.
Financial highlights
Q2 2025 revenue was $14.3M, up 19% year-over-year; operating income was $2.2M, and net income was $1.6M.
Adjusted EBITDA for Q2 2025 was $2.6M, down from $4.0M in Q2 2024; EBITDA was $2.4M, down from $3.7M.
Stockholders' equity stood at $65.7M as of June 30, 2025, with net working capital of $16.4M and cash/cash equivalents of $19.8M.
Cash provided by operations was $4.5M for the six months ended June 30, 2025, down from $7.7M in 2024.
Repurchased 750,000 shares for $1.6M during the quarter; buyback program extended for three years with $7.5M authorized.
Outlook and guidance
Management targets $2M in quarterly operating income as a baseline, aiming to exceed this through organic growth and M&A.
Strong auction and financial asset pipelines expected to drive continued momentum in the second half of 2025.
Management expects to fund operations and debt service for at least 12 months through working capital, cash flows, and credit facility.
No material impact expected from recent tax law changes on the 2025 effective tax rate.
Latest events from Heritage Global
- Q4 2025 revenue rose, DebtX acquisition completed, and 2026 is set for larger transactions.HGBL
Q4 202512 Mar 2026 - Revenue and net income fell as nonaccrual loans surged, but cash and equity improved.HGBL
Q2 20241 Feb 2026 - Strong cash flow and M&A focus position the business for growth amid rising asset supply.HGBL
17th Annual LD Micro Main Event Conference18 Jan 2026 - Earnings and revenue fell, but cash, equity, and M&A activity rose; lending risk remains high.HGBL
Q3 202415 Jan 2026 - Profitability held despite lower revenue and a major default, with strong liquidity and no debt.HGBL
Q4 202424 Dec 2025 - Virtual meeting to elect directors, ratify auditor, and review performance-based executive pay.HGBL
Proxy Filing2 Dec 2025 - Virtual annual meeting to vote on director nominees and auditor ratification June 4, 2025.HGBL
Proxy Filing2 Dec 2025 - Expecting two years of growth as debt charge-offs and surplus auctions accelerate.HGBL
Planet MicroCap Showcase: VEGAS 202528 Nov 2025 - Q1 2025 revenue up 11%, net income down on lending default, but outlook remains strong.HGBL
Q1 202524 Nov 2025